The US Food and Drug Administration (FDA) has officially approved the first drug to combat age-related hyperopia (presbyopia) – eye drops Vuity.
However, the drop cannot be called a full-fledged medicine: the approved drug does not eliminate the causes of visual disturbance, but only temporarily relieves its main symptom.
However, most experts already call this therapy revolutionary, since the regular use of the drops will allow people who have begun to see poorly close up with age to do without reading glasses or working at a computer.
The active ingredient of the drug has long been known to doctors and has been used in the treatment of eye diseases since the 19th century.
